Plain-English translation of NCT06769061 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This pilot trial is testing electroacupuncture as a way to reduce chemotherapy-induced peripheral neuropathy (CIPN)—the nerve pain and tingling that many cancer patients experience after chemotherapy. You would be randomly assigned to receive either real electroacupuncture, sham (fake) acupuncture, or standard care, and researchers will compare how well each approach helps your symptoms over 6 weeks.
Many women who receive chemotherapy for gynecological cancers develop lasting nerve pain and tingling in their hands and feet, and current treatments don't always work well. This trial is exploring whether this treatment might offer relief for patients who haven't found adequate help through standard approaches.
You likely qualify if…
You likely don't qualify if…
If you enroll, you'll have a blood test and complete a screening questionnaire about your nerve pain. Then you'll be randomly assigned to one of three groups: real electroacupuncture (2 sessions per week for 6 weeks, 30 minutes each), sham acupuncture (which looks like real acupuncture but isn't), or standard care while waiting. If you're assigned to sham or standard care, you'll have the option to receive real acupuncture treatments after the study ends.
AI-generated summary from trial data · Jul 7, 2026 · Not medical advice
Hong Kong